Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer

Study objective and procedures The objective of CURIE-LC is to evaluate the feasibility (i.e., whether it is possible and safe) of carrying out a comprehensive exercise program during combined radiotherapy and chemotherapy in patients with lung cancer. The study will assess whether patients can adhere to the exercise program while receiving oncologic treatment and will explore its effects on physical fitness and quality of life. What does participation involve? If participants choose to take part, they will join a supervised exercise program conducted throughout the chemoradiotherapy treatm

Trial Details

NCT ID
NCT07489391
Phase
NA
Sponsor
University of Deusto
Status
RECRUITING
Cancer Type
Non-Small Cell (NSCLC) Lung Cancer
Interventions
  • Multimodal exercise
Locations (sample)
  • Barcelona, Catalonia, Spain|41.38879,2.15899
  • Pamplona, Navarre, Spain|42.81687,-1.64323

Key Eligibility Criteria

  • Histological diagnosis of non-small cell lung cancer (NSCLC) at stage II-III (locally advanced), unresectable/inoperable.
  • Candidate for radical radiotherapy with concomitant chemotherapy, with or without maintenance Durvalumab.
  • ECOG performance status ≤2 (or Karnofsky index ≥60).
  • Ability to communicate adequately with the research team and to complete questionnaires and functional tests.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Non-Small Cell (NSCLC) Lung Cancer Trials on Trialify →